FdaApplication
BLA 125807
Identifiers
- fda_app_no: BLA125807
Properties
| Property | Value |
|---|---|
| applicant_name | Abeona Therapeutics Inc. |
| application_type | BLA |
| approval_date | 2025-04-28 |
Revenue by product
ZEVASKYN
| Period | Revenue |
|---|---|
| Q2 2026 | $11.4M |
| Q1 2026 | $8.7M† |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients. A figure marked † is the company's one reported revenue line rather than a product breakdown.
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZEVASKYN | — | 41.25CM^2 | Cellular Sheet |
1 product